QGEN

#958
QIAGEN N.V.
41.89 USD
-0.10%
Sector: Atención Sanitaria
Básica: USD
Divisa de beneficio: USD
Rango diario
41.84
42.00
Rango anual
38.80
57.82
Cambio diario
-0.10%
Variación mensual
+1.75%
Variación en los últimos 6 meses
-11.72%
Cambio anual
-0.59%
Cierres anteriores
41.93
Abrir
42.00
Bid
Ask
Mínimo
41.84
High
42.00
Volumen
347
Ver el calendario completo

Financials

Visión general Informes Estadísticas Dividendos
Trimestre Año
  • Market Capitalization 9.09 B
  • Employee 5 654
  • Founded 1984
  • CEO Thierry Bernard
  • Website www.qiagen.com
  • Headquarter Netherlands
  • FIGI UNKNOWN
  • Industry Technology
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
23.18
Relación precio/flujo de caja
4.79
Dividendos por acción
0.25
Rendimiento por dividendo, %
0.56

Qiagen N.V

QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE and at the Frankfurt Stock Exchange in the Prime Standard. Thierry Bernard is the company's Chief Executive Officer.

Noticias